Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

Cheap OEM Software
  

Search in our Online Store
Other Disease Areas
Filter     Order     Display # 
Date Item Title
20 May 2008 Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
20 May 2008 Halozyme Therapeutics Presents Pre-Clinical Studies on Dermal Remodeling With HTI-501, a Lysosomal Proteinase
19 May 2008 Ipsen and Medicis Announce Acceptance of Reloxin BLA in Aesthetics by FDA
19 May 2008 Positive Clinical Data with Santarus' ZEGERID Capsules in Controlling 24-Hour Gastric Acidity Presented in DDW Abstract
19 May 2008 New AMITIZA 8 mcg Phase III Studies Demonstrated Overall Symptom Improvement in Adult Women with Irritable Bowel Syndrome with Constipation (IBS-C)
19 May 2008 TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis
16 May 2008 Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease
16 May 2008 Inspire Receives Milestone Payment for Completion of Phase 3 Testing in Japan for Dry Eye Program
15 May 2008 Lpath's iSONEP(TM) IND Application Gets Green Light From FDA
15 May 2008 Protox Doses First Patient In Phase 2 BPH Clinical Trial
15 May 2008 Trophos Starts Phase II Clinical Trial of TRO19622 in Liver Disease
14 May 2008 Platin Technologies announces new strategis objectives and reports third quater 2008 financial results
14 May 2008 Ęterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
12 May 2008 Theratechnologies and PDC Biotech GmbH sign license agreement for family of peptides for Preterm Labour and Primary Dysmenorrhea programs
12 May 2008 Affymax and Takeda Announce Long-Term Hematide Safety and Effectiveness Data from Phase 2 Clinical Trials in Chronic Kidney Disease Patients with Anemia
12 May 2008 Repros Therapeutics Inc. Announces That Proellex Shows No Adverse Cardiac Effects In A Pilot Trial
09 May 2008 Adolor Provides Regulatory Update on Entereg(R) (alvimopan)
08 May 2008 pSivida Announces Start of Clinical Trial to Assess Safety and Efficacy of Medidur(TM) FA in Patients with Age Related Macular Degeneration Treated with Lucentis(R)
08 May 2008 OrthoLogic Announces Positive Safety Data for Initial AZX100 Phase 1 Human Clinical Trial in Dermal/Hypertrophic Scarring
07 May 2008 Acucela Files Investigational New Drug Application
06 May 2008 NicOx announces U.S. phase 2a results for PF-03187207
05 May 2008 Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea
05 May 2008 Can-Fite Successfully Completed Phase I Clinical Trial with its 2nd Drug CF102
05 May 2008 QLTE completes enrollment in the radical study
02 May 2008 Discovery Labs Receives an Approvable Letter from FDA for Surfaxin(R) for RDS
01 May 2008 ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
30 Apr 2008 AstraZeneca Submits sNDA for SYMBICORT(R) for COPD Treatment
30 Apr 2008 Sucampo Pharmaceuticals Obtains FDA Approval for AMITIZA(R) for the Treatment of Irritable Bowel Syndrome with Constipation in Adult Women
30 Apr 2008 Orexo reports positive results from phase I study for OX19
29 Apr 2008 Medtronic and Scil Technology Establish Partnership for Dental Bone Regeneration Therapies
28 Apr 2008 Targeted Genetics Announces Data From First Gene Therapy Trial for Leber's Congenital Amaurosis in New England Journal of Medicine
28 Apr 2008 North Park Aesthetics Acquires Exclusive Worldwide Rights to Develop and Commercialize Fluridil, a Novel Antiandrogen for Androgenetic Alopecia
28 Apr 2008 Regeneron and Bayer HealthCare Announce Encouraging 32-Week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-Related Macular Degeneration
25 Apr 2008 European Regulatory Authority (EMEA) Recommends Granting of Marketing Authorization for MediGene's Drug Oracea(R)
25 Apr 2008 Progenics and Wyeth Announce FDA Has Approved RELISTOR
25 Apr 2008 Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
24 Apr 2008 Addex Starts ADX10059 Phase I Formulation Selection Study
24 Apr 2008 NOVAGALI PHARMA Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
24 Apr 2008 Lux Biosciences Reports on Pivotal Programs in Uveitis
24 Apr 2008 ESBATech's Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
24 Apr 2008 Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
23 Apr 2008 ReNeuron announces further pre-clinical data with its ReN003 programme for diseases of the retina
23 Apr 2008 Results from renzapride
22 Apr 2008 Spectrum Pharmaceuticals Provides an Update on Ozarelix in BPH
21 Apr 2008 InterMune Announces Progress on Pirfenidone in IPF
14 Apr 2008 Lpath Submits Investigational New Drug Application for iSONEP(TM)
10 Apr 2008 Jerini Ophthalmic and PR Pharmaceuticals Sign Collaboration Agreement to Develop Sustained-Release Formulations for the Treatment of Eye Diseases
09 Apr 2008 Barrier Therapeutics announces positive results in reducing itch symptoms with novel oral antihistamine agent Hivenyl
08 Apr 2008 Protox Initiates Phase 2 BPH Study
07 Apr 2008 Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Results 201 - 250 of 985

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Diabetes Drug Pipeline

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics